Myotoxic drugs and immunodeficiency may contribute to the poor outcome of COVID-19 patients with myotonic dystrophy.

Título

Myotoxic drugs and immunodeficiency may contribute to the poor outcome of COVID-19 patients with myotonic dystrophy.

Autor

Josef Finsterer

Fecha

2021

Materia

covid-19, SARS-CoV-2, encephalitis, MRI, Brain

Identificador

10.1007/s13760-020-01551-8

Fuente

Acta neurologica Belgica

Archivos

https://socictopen.socict.org/files/to_import/pdfs/24ccd29ad99189592229bdbb2e5a7ad5.pdf

Colección

Coronavirus

Citación

Josef Finsterer, “Myotoxic drugs and immunodeficiency may contribute to the poor outcome of COVID-19 patients with myotonic dystrophy.,” SOCICT Open, consulta 21 de abril de 2026, https://socictopen.socict.org/items/show/8169.

Formatos de Salida

Position: 20618 (10 views)